Posted inNews and Updates
India’s Digital Drug Trial Rules: Key Regulatory Shifts
India’s new regulatory framework for digital drug trials mandates modern data standards to improve research efficiency, patient safety, and global compliance.
Posted inNews and Updates
FDA Clears Clinical Trial for CAR T-Cell MS Therapy
The FDA has authorized clinical trials for CAR T-cell therapy in progressive MS, marking a potential breakthrough in neuro-immunology treatment strategies.
Posted inNews and Updates
FDA Accelerates Clinical Trials Through New Pilot Program
The FDA is launching a new program to speed up clinical trials by linking drugmakers with research centers early in the development process.
Posted inNews and Updates
Endogenex ReCET Clinical Study Reaches Full Enrollment
Endogenex has completed enrollment for its ReCET clinical trial. Discover how this endoscopic therapy aims to transform Type 2 diabetes management.
Posted inNews and Updates
Why Slow Clinical Trials Are Stalling India’s Pharma Ambitions
Stagnant clinical trial timelines are hindering India’s transition from a generic drug supplier to a global innovator. Read why urgent regulatory reform is key.
Posted inNews and Updates
FDA Launches Pilot Program to Expedite IND Applications
The FDA has launched a new pilot program to accelerate IND applications, aiming to streamline clinical trial entry and foster medical innovation.
Posted inNews and Updates
Huntington’s Disease: SKY-0515 Trial Shows Positive Results
Skyhawk Therapeutics reports positive 15-month Phase 1/2 data for SKY-0515, a promising small-molecule treatment for Huntington’s disease.
Posted inNews and Updates
AI Lung Imaging Outperforms Spirometry in Early Diagnosis
New clinical findings reveal that AI-powered lung scans can detect respiratory damage before spirometry. Explore how this breakthrough shifts diagnostics.
Posted inNews and Updates
Aurobindo Pharma Secures US FDA Approval for Asthma Inhaler
Aurobindo Pharma receives US FDA approval for a generic asthma inhaler. This move aims to increase access to affordable respiratory care for U.S. patients.
Posted inNews and Updates
FDA Debates New Standards for Psychedelic Drug Therapy
The FDA is drafting new safety standards for psychedelic therapies after hearing expert testimony on clinical trial design, safety, and patient care.